News Archive

The National Disease Research Interchange (NDRI) has been awarded more than $800,000 by the National Institutes of Health (NIH) to supplement a current $6.5 million grant provided to NDRI that supports continued national leadership with the recovery and distribution of human organs and tissues for medical research over the course of five years. The supplemental awards provide support for NDRI to serve as a human biospecimen resource for research focused specifically on Alzheimer’s disease, Autism Spectrum Disorder (ASD) and HIV/AIDS. The three awards are supplements to NDRI’s Human Tissues and Organs for Research Resources (HTORR) program which has been supported by the NIH since 1987.

The second minibus package includes the fiscal year 2019 Labor, Health and Human Services, and Education (LHHS) funding bill, which includes funding for programs within the Departments of Labor, Health and Human Services, and Education, and other related agencies, including the Social Security Administration.

Even under the no-holds-barred rules of biotech, it’s a particularly shrewd move, one that might prompt guffaws from knowing insiders.

An artificial intelligence start-up founded by three insiders at Memorial Sloan Kettering Cancer Center debuted with great fanfare in February, with $25 million in venture capital and the promise that it might one day transform how cancer is diagnosed.

This national conference is the cornerstone of the HHS’s congressionally mandated outreach efforts. This three-day national HHS SBIR/STTR Conference is designed to educate attendees about the America’s Largest Seed Fund and how to apply for these research and development dollars. With over $1 billion dollars of annual HHS funding, this is one of the largest sources of early-stage capital for technology commercialization in the United States. The HHS’s SBIR/STTR programs allow US-owned small businesses to forge academic partnerships and build productive businesses. With this funding, the partners can engage in research and development that has a strong potential to deliver products and services, including medical devices, diagnostics, digital health, biotechnology and pharmaceuticals, to improve the health of Americans.

Learning Undefeated is a mobile education program serving Southeast Texas schools devastated by Hurricane Harvey. Using a self-contained science classroom on wheels as its home base, the program provides teaching space and scientific equipment, lab supplies, during- and after-school activities, and public outreach to communities whose classrooms and science labs were destroyed during the August 2017 hurricane.

Monday, October 1, 2018

ACGT and Alexandria Real Estate Equities, Inc., invite you to an Intimate Conversation with Crystal Mackall, MD

In its most recent look at states where innovation and entrepreneurship rank high, the U.S. Department of Commerce Foundation rated Maryland third, highlighting the state as a “national leader in bioscience, biotechnology, and health innovation.”

WellSpan Health and Johns Hopkins Kimmel Cancer Center have partnered to launch a grant program to support cancer research.

The biotechnology industry in the Boston region, especially Cambridge, is a powerhouse even when compared with the innovation and development seen in the San Francisco Bay Area. These hubs function at a whole different level in biotech compared with other biotech clusters in the U.S. The healthy rivalry between San Francisco and Boston has fostered rapid growth in biotech thanks to their robust populations of small startups, large well-established pharmaceuticals, incubator sites, and large biotech-focused research institutions.